RENEGADE RESEARCH

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2024

Legal Domicile

Tax Period

2024-01-01 to 2024-12-31

RENEGADE RESEARCH, founded in 2024, is a small nonprofit in the Medical Research sector that reported $160K in total revenue in fiscal year 2024. The organization ran a surplus of $26K, a strong 16% operating margin.

Mission

RENEGADE RESEARCH IS DRIVEN BY THE VISION TO EMPOWER CHRONIC ILLNESS PATIENTS THROUGH COLLABORATIVE RESEARCH AND INNOVATIVE SELF-EXPERIMENTATION. OUR MISSION IS CENTERED ON PIONEERING ACCESSIBLE PATIENT-LED EFFORTS TO UNCOVER SCIENTIFIC INSIGHTS & IMPROVE OVERALL QUALITY OF LIFE

Program Service Accomplishments

Program 1

Expenses: $119,297

REMISSION BIOME RESEARCH IS AN EXPERIMENTAL, MEDICALLY SUPERVISED, PROTOCOL TITLED REMISSION BIOME TO HELP PATIENTS WITH ME/CFS (MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME) AND LONG COVID TO POTENTIALLY ACHIEVE A HIGHER BASELINE IN FUNCTION AND IMPROVE THEIR QUALITY OF LIFE. OUR INITIAL RESULTS ARE ENCOURAGING AND AT PRESENT, WE ARE EXPANDING THE SCOPE OF THIS PROJECT TO INCLUDE MORE PATIENTS.

Program 2

Expenses: $6,189

PUBLIC EDUCATION SEMINARS ARE TO HOST RESEARCH AND CLINICAL EDUCATIONAL SEMINARS ABOUT ME/CFS (MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME), LONG COVID, AND RELATED CONDITIONS FOR RESEARCHERS, CLINICIANS, AND THE PUBLIC TO ATTEND. THESE SEMINARS ARE RECORDED AND POSTED ON OUR YOUTUBE CHANNEL FOR PUBLIC VIEWING FROM PEOPLE WHO CANNOT ATTEND REAL TIME.

Program 3

Expenses: $337

LACTATE TESTING AND RESEARCH IN A RESEARCH PROJECT THAT IS LED BY INDIVIDUALS WITH ME/CFS (MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME), LONG COVID, PERFORMING SELF-EXPERIMENTATION TO TEST A HYPOTHESIS, ANALYZE THE DATA, REVIEW THEIR HYPOTHESIS AND CONTINUE AS THE DATA GUIDES THEM. THIS WAS BASED ON PREVIOUS RESEARCH OF HIGH LACTATE LEVELS IN PATIENTS. THE RESULTS WILL BE SHARED IN AN OPEN-SOURCE FORMAT. A PUBLICATION IS CURRENTLY BEING WRITTEN.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $159,837

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $159,837

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $125,823

Other Expenses $134,050

TOTAL EXPENSES $134,050

Year-over-Year Comparison

	2024	2023	Change
Revenue	$159,837	N/A	N/A
Expenses	$134,050	N/A	N/A
Net Income	$25,787	N/A	N/A

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ISABEL BURNETT	DIRECTOR	1.00	Director	$0	$0	$0
TESS FALOR	DIRECTOR	1.00	Director	$0	$0	$0
MARIE JOBIN	PRESIDENT	1.00	Officer Director	$0	$0	$0
SHELLEY HAYDEN	SECRETARY	1.00	Officer Director	$0	$0	$0
ANA SOFIA PINHO	TREASURER	1.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$159,837	$134,050	$25,787	$25,787